S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00

Compare Stocks

Date Range: 

 Regeneron PharmaceuticalsTakeda PharmaceuticalBayer AktiengesellschaftVertex PharmaceuticalsZoetis
SymbolNASDAQ:REGNNYSE:TAKOTCMKTS:BAYRYNASDAQ:VRTXNYSE:ZTS
Price Information
Current Price$589.60$13.82$14.20$180.94$209.58
50-Day Moving Average$624.74$16.30$13.80$189.25$202.11
52-Week Low$441.00$13.81$11.65$176.36$141.41
52-Week High$686.62$19.97$17.34$242.99$211.77
MarketRank™
Overall Score2.81.82.32.82.4
Analysis Score3.40.03.34.31.4
Community Score4.53.94.35.05.0
Dividend Score0.03.32.50.01.7
Ownership Score3.30.00.03.32.5
Earnings & Valuation Score2.51.91.31.31.3
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$703.75N/A$60.00$266.61$203.11
% Upside from Price Target19.36% upsideN/A322.68% upside47.35% upside-3.09% downside
Trade Information
Market Cap$63.06 billion$43.73 billion$55.78 billion$46.94 billion$99.33 billion
Beta0.161.051.270.630.64
Average Volume857,3442,720,755457,4121,958,0191,746,369
Sales & Book Value
Annual Revenue$8.50 billion$30.17 billion$47.29 billion$6.21 billion$6.68 billion
Price / Sales7.421.451.187.5614.88
Cashflow$30.27 per share$2.97 per share$5.96 per share$9.18 per share$4.87 per share
Price / Cash19.484.662.3819.7043.06
Book Value$102.91 per share$15.42 per share$8.92 per share$33.41 per share$7.94 per share
Price / Book5.730.901.595.4226.40
Profitability
Net Income$3.51 billion$3.53 billion$-11.99 billion$2.71 billion$1.64 billion
EPS$28.66$1.98$1.82$9.03$3.85
Trailing P/E Ratio10.599.47N/A23.8752.53
Forward P/E Ratio13.3714.707.0315.8740.85
P/E Growth0.77N/A3.321.773.31
Net Margins50.11%14.69%-6.30%29.80%25.76%
Return on Equity (ROE)50.43%13.00%19.76%29.73%53.87%
Return on Assets (ROA)33.56%5.11%5.37%21.96%15.44%
Dividend
Annual PayoutN/A$0.68$0.41N/A$1.00
Dividend YieldN/A4.92%2.89%N/A0.48%
Three-Year Dividend GrowthN/A6.41%N/AN/AN/A
Payout RatioN/A34.34%22.53%N/A25.97%
Years of Consecutive Dividend GrowthN/AN/AN/AN/A1 Years
Debt
Debt-to-Equity Ratio0.130.831.200.061.51
Current Ratio3.571.511.164.613.37
Quick Ratio3.041.030.804.432.51
Ownership Information
Institutional Ownership Percentage82.31%2.99%0.11%88.63%89.53%
Insider Ownership Percentage11.84%N/AN/A0.70%0.17%
Miscellaneous
Employees9,1232,02199,5383,40011,300
Shares Outstanding106.96 million3.16 billion3.93 billion259.43 million473.94 million
Next Earnings Date11/4/2021 (Confirmed)11/4/2021 (Estimated)11/2/2021 (Estimated)11/2/2021 (Confirmed)11/4/2021 (Confirmed)
OptionableOptionableOptionableNot OptionableOptionableOptionable
SourceHeadline
Commercial Aquaculture Vaccines Market 2021-2027: Major Trends and Key Developments | Zoetis LLC, Merck & Co. Inc. (MSD Animal Health), Laboratorios Hipra SA, Elanco Animal Health Inc – The Host - The HostCommercial Aquaculture Vaccines Market 2021-2027: Major Trends and Key Developments | Zoetis LLC, Merck & Co. Inc. (MSD Animal Health), Laboratorios Hipra SA, Elanco Animal Health Inc – The Host - The Host
thehostonline.co.uk - October 28 at 12:37 AM
Animal Genetics Market Overall Study Report 2021-2028 | Zoetis, Topigs Norsvin Holding B.V., Genus Plc, Envigo - openPRAnimal Genetics Market Overall Study Report 2021-2028 | Zoetis, Topigs Norsvin Holding B.V., Genus Plc, Envigo - openPR
openpr.com - October 28 at 12:37 AM
Animal Pharmaceutical Market Size and Forecast | Key Companies – Zoetis, Merck, Merial, Elanco, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Virbac, Ceva Sante Animale, Vétoquinol, Jurox, – The Host - The HostAnimal Pharmaceutical Market Size and Forecast | Key Companies – Zoetis, Merck, Merial, Elanco, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Virbac, Ceva Sante Animale, Vétoquinol, Jurox, – The Host - The Host
thehostonline.co.uk - October 28 at 12:37 AM
Veterinary Pain Management Market Top Players Analysis: Boehringer Ingelheim, Chanelle, Merck Animal Health, Zoetis, Norbrook Laboratories, Elanco, Assisi Animal Health, Vetoquinol, Bayer, K-Laser – The Host - The HostVeterinary Pain Management Market Top Players Analysis: Boehringer Ingelheim, Chanelle, Merck Animal Health, Zoetis, Norbrook Laboratories, Elanco, Assisi Animal Health, Vetoquinol, Bayer, K-Laser – The Host - The Host
thehostonline.co.uk - October 28 at 12:37 AM
Hedge Fund and Insider Trading News: Jeff Ubben, Leon Cooperman, Invenomic Capital Management, Third Point LLC, SkyBridge Capital, Man Group, Zoetis Inc (ZTS), Eyenovia Inc (EYEN), and MoreHedge Fund and Insider Trading News: Jeff Ubben, Leon Cooperman, Invenomic Capital Management, Third Point LLC, SkyBridge Capital, Man Group, Zoetis Inc (ZTS), Eyenovia Inc (EYEN), and More
feedproxy.google.com - October 27 at 3:55 PM
Audubon Zoo and Aquarium begin process to vaccinate animals - InPark MagazineAudubon Zoo and Aquarium begin process to vaccinate animals - InPark Magazine
inparkmagazine.com - October 27 at 2:36 PM
Experimental US vaccine promises to reduce Covid-19 risks for animals - La Prensa LatinaExperimental US vaccine promises to reduce Covid-19 risks for animals - La Prensa Latina
laprensalatina.com - October 27 at 2:36 PM
Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for October 28, 2021 - NasdaqZoetis Inc. (ZTS) Ex-Dividend Date Scheduled for October 28, 2021 - Nasdaq
nasdaq.com - October 27 at 2:36 PM
Zoetis defended at BofA amid reports of anti-trust probe in EU - Seeking AlphaZoetis defended at BofA amid reports of anti-trust probe in EU - Seeking Alpha
seekingalpha.com - October 27 at 2:36 PM
Zoetis Inc. (ZTS) EU Investigation Quantified at BofA Securities - StreetInsider.comZoetis Inc. (ZTS) EU Investigation Quantified at BofA Securities - StreetInsider.com
streetinsider.com - October 27 at 9:36 AM
Companion Animal Vaccines Market May See Big Move | Pfizer, Zoetis, Virbac, Merial - Big News NetworkCompanion Animal Vaccines Market May See Big Move | Pfizer, Zoetis, Virbac, Merial - Big News Network
bignewsnetwork.com - October 26 at 11:26 PM
Zoetis (NYSE: ZTS) Executives are Making Moves with Their Shares - Analyst RatingsZoetis (NYSE: ZTS) Executives are Making Moves with Their Shares - Analyst Ratings
analystratings.com - October 26 at 11:26 PM
Zoetis: Expensive But Precision Livestock Farming Division Could Be Game Changer - Seeking AlphaZoetis: Expensive But Precision Livestock Farming Division Could Be Game Changer - Seeking Alpha
seekingalpha.com - October 26 at 1:25 PM
South America Poultry Vaccines Market Is Likely to Experience - openPRSouth America Poultry Vaccines Market Is Likely to Experience - openPR
openpr.com - October 26 at 7:50 AM
Global Veterinary Pain Management Drugs Market 2021 Key Drivers – Boehringer Ingelheim, Merck & Co, Zoetis, Elanco – IMIESA - IMIESAGlobal Veterinary Pain Management Drugs Market 2021 Key Drivers – Boehringer Ingelheim, Merck & Co, Zoetis, Elanco – IMIESA - IMIESA
infrastructurene.ws - October 26 at 7:50 AM
Zoetis Inc. (ZTS) Executive Vice President Holds 20244.0 Worth Of Stock - The Fosters LeaderZoetis Inc. (ZTS) Executive Vice President Holds 20244.0 Worth Of Stock - The Fosters Leader
fostersleader.com - October 25 at 3:34 PM
Zoetis (NYSE:ZTS) Hits New 12-Month High at $210.46Zoetis (NYSE:ZTS) Hits New 12-Month High at $210.46
americanbankingnews.com - October 25 at 12:40 PM
Animal Antibacterial and Antibiotics Market Size and Forecast 2028 | Key Companies – Zoetis, Merck Animal Health, Merial, Elanco, Bayer HealthCare, Biog�nesis Bag� - The Manomet CurrentAnimal Antibacterial and Antibiotics Market Size and Forecast 2028 | Key Companies – Zoetis, Merck Animal Health, Merial, Elanco, Bayer HealthCare, Biog�nesis Bag� - The Manomet Current
manometcurrent.com - October 25 at 10:33 AM
Veterinary Glucometers Market Size and Forecast | Key Players – Zoetis, Abbott, Woodley Equipment Company Ltd., Nova Biomedical, BioNote Inc., Arkray, UltiMed, Medray, Biotest Medical Corp., – Puck77 - Puck77Veterinary Glucometers Market Size and Forecast | Key Players – Zoetis, Abbott, Woodley Equipment Company Ltd., Nova Biomedical, BioNote Inc., Arkray, UltiMed, Medray, Biotest Medical Corp., – Puck77 - Puck77
puck77.com - October 24 at 1:32 PM
Pet Drug Market Past Research, Deep Analysis and Present Data With Zoetis, Boehringer Ingelheim, Merck Animal Health – Puck77 - Puck77Pet Drug Market Past Research, Deep Analysis and Present Data With Zoetis, Boehringer Ingelheim, Merck Animal Health – Puck77 - Puck77
puck77.com - October 24 at 1:32 PM
Spain Veterinary Healthcare Market Size, Growth 2028 | Key Companies – Zoetis, Merck, Merial, Elanco, Bayer Animal Health, Hipra – Puck77 - Puck77Spain Veterinary Healthcare Market Size, Growth 2028 | Key Companies – Zoetis, Merck, Merial, Elanco, Bayer Animal Health, Hipra – Puck77 - Puck77
puck77.com - October 24 at 1:01 AM
Veterinary Products Market Forecast to 2025 with Global Key Companies Profile | Zoetis, Merck Animal Health, Parnell, Meiji, Boehringer Ingelheim, etc – Puck77 - Puck77Veterinary Products Market Forecast to 2025 with Global Key Companies Profile | Zoetis, Merck Animal Health, Parnell, Meiji, Boehringer Ingelheim, etc – Puck77 - Puck77
puck77.com - October 24 at 1:01 AM
Bovine Mastitis Market Impact and Recovery Analysis| Zoetis, MSD Animal Health, Boehringer Ingelheim International – Puck77 - Puck77Bovine Mastitis Market Impact and Recovery Analysis| Zoetis, MSD Animal Health, Boehringer Ingelheim International – Puck77 - Puck77
puck77.com - October 23 at 8:00 PM
Praziquantel Market Witness Stunning Growth By 2028 | Bayer, Zoetis, Richter Pharma – Puck77 - Puck77Praziquantel Market Witness Stunning Growth By 2028 | Bayer, Zoetis, Richter Pharma – Puck77 - Puck77
puck77.com - October 23 at 3:00 PM
States Pet Noise Anxiety Market to Witness Huge Growth by 2028 | Zoetis, VioVet, PetMed Express – Puck77 - Puck77States Pet Noise Anxiety Market to Witness Huge Growth by 2028 | Zoetis, VioVet, PetMed Express – Puck77 - Puck77
puck77.com - October 23 at 3:00 PM
The “Dividend Magnet” Could Pull These 43 Stocks Higher (10%-50% Growth Ahead)The “Dividend Magnet” Could Pull These 43 Stocks Higher (10%-50% Growth Ahead)
marketbeat.com - October 13 at 10:01 PM
DateCompanyBrokerageAction
10/26/2021Regeneron PharmaceuticalsSVB Leerink
Boost Price Target
10/22/2021Regeneron PharmaceuticalsHC Wainwright
Boost Price Target
10/21/2021Bayer AktiengesellschaftMorgan Stanley
Reiterated Rating
10/12/2021Regeneron PharmaceuticalsMorgan Stanley
Lower Price Target
10/6/2021Takeda PharmaceuticalMorgan Stanley
Downgrade
10/4/2021Regeneron PharmaceuticalsHC Wainwright
Reiterated Rating
9/21/2021Regeneron PharmaceuticalsBMO Capital Markets
Boost Price Target
9/15/2021Regeneron PharmaceuticalsPiper Sandler
Boost Price Target
9/15/2021Regeneron PharmaceuticalsCantor Fitzgerald
Boost Price Target
9/15/2021Regeneron PharmaceuticalsHC Wainwright
Boost Price Target
9/9/2021Regeneron PharmaceuticalsUBS Group
Initiated Coverage
9/9/2021Vertex PharmaceuticalsStifel Nicolaus
Downgrade
9/7/2021Regeneron PharmaceuticalsMorgan Stanley
Boost Price Target
9/7/2021Vertex PharmaceuticalsMorgan Stanley
Downgrade
8/25/2021ZoetisArgus
Boost Price Target
8/23/2021Regeneron PharmaceuticalsBenchmark
Boost Price Target
8/20/2021Regeneron PharmaceuticalsHC Wainwright
Reiterated Rating
8/9/2021Bayer AktiengesellschaftBerenberg Bank
Lower Price Target
8/9/2021ZoetisCredit Suisse Group
Boost Price Target
8/6/2021Regeneron PharmaceuticalsBarclays
Boost Price Target
8/6/2021Regeneron PharmaceuticalsSVB Leerink
Boost Price Target
8/6/2021Regeneron PharmaceuticalsBMO Capital Markets
Boost Price Target
8/6/2021Regeneron PharmaceuticalsOppenheimer
Boost Price Target
8/6/2021Bayer AktiengesellschaftCredit Suisse Group
Reiterated Rating
8/6/2021ZoetisBarclays
Boost Price Target
8/5/2021Regeneron PharmaceuticalsPiper Sandler
Boost Price Target
8/4/2021Bayer AktiengesellschaftAlphaValue
Downgrade
8/2/2021Regeneron PharmaceuticalsHC Wainwright
Boost Price Target
7/30/2021Vertex PharmaceuticalsMorgan Stanley
Lower Price Target
7/30/2021Vertex PharmaceuticalsRoyal Bank of Canada
Boost Price Target
7/30/2021Vertex PharmaceuticalsSVB Leerink
Boost Price Target
7/30/2021Vertex PharmaceuticalsPiper Sandler
Boost Price Target
7/23/2021Regeneron PharmaceuticalsRoyal Bank of Canada
Boost Price Target
7/20/2021Vertex PharmaceuticalsSVB Leerink
Downgrade
7/19/2021Vertex PharmaceuticalsWolfe Research
Initiated Coverage
7/16/2021ZoetisRaymond James
Downgrade
7/13/2021ZoetisCantor Fitzgerald
Boost Price Target
7/8/2021Regeneron PharmaceuticalsBenchmark
Boost Price Target
6/30/2021Vertex PharmaceuticalsRaymond James
Initiated Coverage
6/29/2021Regeneron PharmaceuticalsHC Wainwright
Initiated Coverage
6/25/2021Bayer AktiengesellschaftKepler Capital Markets
Reiterated Rating
6/14/2021Vertex PharmaceuticalsTruist
Boost Price Target
6/14/2021Vertex PharmaceuticalsPiper Sandler
Lower Price Target
6/14/2021Vertex PharmaceuticalsTruist Securities
Boost Price Target
6/14/2021Vertex PharmaceuticalsSVB Leerink
Lower Price Target
6/13/2021Vertex PharmaceuticalsEvercore ISI
Reiterated Rating
6/11/2021Vertex PharmaceuticalsStifel Nicolaus
Lower Price Target
6/11/2021Vertex PharmaceuticalsThe Goldman Sachs Group
Lower Price Target
6/11/2021Vertex PharmaceuticalsBarclays
Lower Price Target
6/11/2021Vertex PharmaceuticalsCantor Fitzgerald
Lower Price Target
6/11/2021Vertex PharmaceuticalsMorgan Stanley
Lower Price Target
6/11/2021Vertex PharmaceuticalsRobert W. Baird
Lower Price Target
6/11/2021Vertex PharmaceuticalsRoyal Bank of Canada
Lower Price Target
6/11/2021Vertex PharmaceuticalsDaiwa Capital Markets
Downgrade
5/28/2021ZoetisArgus
Boost Price Target
5/26/2021Bayer AktiengesellschaftDZ Bank
Reiterated Rating
5/19/2021Bayer AktiengesellschaftMorgan Stanley
Reiterated Rating
5/18/2021Bayer AktiengesellschaftJPMorgan Chase & Co.
Upgrade
5/14/2021Bayer AktiengesellschaftDZ Bank
Reiterated Rating
5/13/2021Bayer AktiengesellschaftCredit Suisse Group
Reiterated Rating
5/13/2021Bayer AktiengesellschaftBryan, Garnier & Co
Upgrade
5/12/2021ZoetisCitigroup
Boost Price Target
5/7/2021Regeneron PharmaceuticalsSVB Leerink
Lower Price Target
5/7/2021Regeneron PharmaceuticalsMorgan Stanley
Boost Price Target
5/7/2021ZoetisRaymond James
Boost Price Target
5/7/2021ZoetisBarclays
Boost Price Target
5/3/2021Vertex PharmaceuticalsMorgan Stanley
Boost Price Target
4/26/2021Vertex PharmaceuticalsMorgan Stanley
Boost Price Target
4/19/2021Regeneron PharmaceuticalsMorgan Stanley
Lower Price Target
4/19/2021Takeda PharmaceuticalJPMorgan Chase & Co.
Downgrade
4/19/2021Vertex PharmaceuticalsMorgan Stanley
Boost Price Target
4/13/2021Regeneron PharmaceuticalsRobert W. Baird
Reiterated Rating
4/5/2021Takeda PharmaceuticalJefferies Financial Group
Downgrade
3/30/2021Bayer AktiengesellschaftDZ Bank
Reiterated Rating
3/19/2021Bayer AktiengesellschaftDeutsche Bank Aktiengesellschaft
Reiterated Rating
3/11/2021Bayer AktiengesellschaftSociete Generale
Reiterated Rating
3/8/2021ZoetisRaymond James
Upgrade
3/8/2021ZoetisBank of America
Upgrade
3/4/2021Bayer AktiengesellschaftBerenberg Bank
Reiterated Rating
3/1/2021Bayer AktiengesellschaftMorgan Stanley
Reiterated Rating
3/1/2021Bayer AktiengesellschaftDZ Bank
Reiterated Rating
2/26/2021Bayer AktiengesellschaftCredit Suisse Group
Reiterated Rating
2/17/2021ZoetisCredit Suisse Group
Boost Price Target
2/10/2021Bayer AktiengesellschaftBarclays
Reiterated Rating
2/4/2021Bayer AktiengesellschaftDZ Bank
Reiterated Rating
1/27/2021Bayer AktiengesellschaftDeutsche Bank Aktiengesellschaft
Reiterated Rating
1/20/2021Bayer AktiengesellschaftCredit Suisse Group
Reiterated Rating
1/8/2021Bayer AktiengesellschaftMorgan Stanley
Reiterated Rating
1/6/2021Bayer AktiengesellschaftNord/LB
Reiterated Rating
11/13/2020ZoetisMorgan Stanley
Boost Price Target
11/12/2020ZoetisTruist
Boost Price Target
11/6/2020Bayer AktiengesellschaftMorgan Stanley
Reiterated Rating
11/6/2020ZoetisBarclays
Boost Price Target
9/21/2020ZoetisAtlantic Securities
Initiated Coverage
8/20/2020ZoetisMorgan Stanley
Boost Price Target
8/14/2020ZoetisEdward Jones
Upgrade
8/12/2020ZoetisG.Research
Downgrade
8/12/2020ZoetisGabelli
Downgrade
8/10/2020ZoetisTruist Financial
Boost Price Target
8/10/2020ZoetisCitigroup
Boost Price Target
8/7/2020ZoetisStifel Nicolaus
Boost Price Target
7/30/2020ZoetisCitigroup
Boost Price Target
7/20/2020ZoetisBank of America
Boost Price Target
3/11/2020Takeda PharmaceuticalJPMorgan Chase & Co.
Lower Price Target
11/1/2019Takeda PharmaceuticalCowen
Initiated Coverage
9/24/2019Takeda PharmaceuticalJefferies Financial Group
Initiated Coverage
8/15/2019Takeda PharmaceuticalDaiwa Capital Markets
Downgrade
3/19/2019Takeda PharmaceuticalThe Goldman Sachs Group
Reiterated Rating
(Data available from 10/28/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.